Stephane Bancel

2 articles

US FDA Approves First mRNA Flu Vaccine

The FDA approved Moderna's mFLUSIVA, the first mRNA-based influenza vaccine, for US adults aged 50 and older in the 2026–27 flu season. This milestone marks a key modernization step in vaccine develop

cen · 2026-08-07 00:00

Moderna Interested in Germany Production, Sees Opportunity in BioNTech Closures, Says CEO

Moderna CEO Stephane Bancel expressed interest in acquiring BioNTech's planned-to-close German production facilities, citing them as a cost-effective alternative to new builds pending government partn

reuters · 2026-06-16 23:38